Genetic and Molecular Biology of Multiple Sclerosis Among Iranian Patients: An Overview
- 80 Downloads
Multiple sclerosis (MS) is one if the common types of autoimmune disorders in developed countries. Various environmental and genetic factors are associated with initiation and progression of MS. It is believed that the life style changes can be one of the main environmental risk factors. The environmental factors are widely studied and reported, whereas minority of reports have considered the role of genetic factors in biology of MS. Although Iran is a low-risk country in the case of MS prevalence, it has been shown that there was a dramatically rising trend of MS prevalence among Iranian population during recent decades. Therefore, it is required to assess the probable MS risk factors in Iran. In the present study, we summarized all of the reported genes until now which have been associated with MS susceptibility among Iranian patients. To clarify the probable molecular biology of MS progression, we categorized these reported genes based on their cellular functions. This review paves the way of introducing a specific population-based diagnostic panel of genetic markers among the Iranian population for the first time in the world.
KeywordsMultiple sclerosis Genetic Risk factor Iran
MM prepared and edited the draft.
Compliance with Ethical Standards
Conflict of interest
The authors declare that they have no conflict of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
- Akcali A, Pehlivan S, Pehlivan M, Sever T, Akgul P, Neyal M (2010) TNF-alpha promoter polymorphisms in multiple sclerosis: no association with -308 and -238 alleles, but the -857 alleles in associated with the disease in Turkish patients. Int J immunogenet 37:91–95. https://doi.org/10.1111/j.1744-313x.2009.00895.x CrossRefPubMedGoogle Scholar
- Austin PJ et al (2017) Transcriptional profiling identifies the long noncoding RNA plasmacytoma variant translocation (PVT1) as a novel regulator of the asthmatic phenotype in human airway smooth muscle. J Allergy Clin Immunol 139:780–789. https://doi.org/10.1016/j.jaci.2016.06.014 CrossRefPubMedPubMedCentralGoogle Scholar
- Azimi T, Ghafouri-Fard S, Davood Omrani M, Mazdeh M, Arsang-Jang S, Sayad A, Taheri M (2018) Vaccinia related kinase 2 (VRK2) expression in neurological disorders: schizophrenia, epilepsy and multiple sclerosis. Mult Scler Relat Disord 19:15–19. https://doi.org/10.1016/j.msard.2017.10.017 CrossRefPubMedGoogle Scholar
- Bermudez-Morales VH, Fierros G, Lopez RL, Martinez-Nava G, Flores-Aldana M, Flores-Rivera J, Hernandez-Giron C (2017) Vitamin D receptor gene polymorphisms are associated with multiple sclerosis in Mexican adults. J Neuroimmunol 306:20–24. https://doi.org/10.1016/j.jneuroim.2017.01.009 CrossRefPubMedGoogle Scholar
- Bufler P, Gamboni-Robertson F, Azam T, Kim SH, Dinarello CA (2004) Interleukin-1 homologues IL-1F7b and IL-18 contain functional mRNA instability elements within the coding region responsive to lipopolysaccharide. Biochem J 381:503–510. https://doi.org/10.1042/bj20040217 CrossRefPubMedPubMedCentralGoogle Scholar
- Hassanzadeh G, Hosseini Quchani S, Sahraian MA, Abolhassani F, Sadighi Gilani MA, Dehghan Tarzjani M, Atoof F (2016) Leukocyte gene expression and plasma concentration in multiple sclerosis: alteration of transforming growth factor-betas, claudin-11, and matrix metalloproteinase-2. Cell Mol Neurobiol 36:865–872. https://doi.org/10.1007/s10571-015-0270-y CrossRefGoogle Scholar
- Honardoost MA, Kiani-Esfahani A, Ghaedi K, Etemadifar M, Salehi M (2014) miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis. Gene 544:128–133. https://doi.org/10.1016/j.gene.2014.04.069 CrossRefPubMedGoogle Scholar
- Jafarzadeh A et al (2014) Higher circulating levels of chemokine CCL20 in patients with multiple sclerosis: evaluation of the influences of chemokine gene polymorphism, gender, treatment and disease pattern. J Mol Neurosci 53:500–505. https://doi.org/10.1007/s12031-013-0214-2 CrossRefPubMedGoogle Scholar
- Javan MR, Shahraki S, Safa A, Zamani MR, Salmaninejad A, Aslani S (2017) An interleukin 12 B single nucleotide polymorphism increases IL-12p40 production and is associated with increased disease susceptibility in patients with relapsing-remitting multiple sclerosis. Neurol Res 39:435–441. https://doi.org/10.1080/01616412.2017.1301623 CrossRefPubMedGoogle Scholar
- Karami M, Mehrabi F, Allameh A, Pahlevan Kakhki M, Amiri M, Emami Aleagha MS (2017) Klotho gene expression decreases in peripheral blood mononuclear cells (PBMCs) of patients with relapsing-remitting multiple sclerosis. J Neurol Sci 381:305–307. https://doi.org/10.1016/j.jns.2017.09.012 CrossRefPubMedGoogle Scholar
- Kouchaki E, Tamtaji OR, Dadgostar E, Karami M, Nikoueinejad H, Akbari H (2017) Correlation of serum levels of IL-33, IL-37, soluble form of vascular endothelial growth factor receptor 2 (VEGFR2), and circulatory frequency of VEGFR2-expressing cells with multiple sclerosis severity. Iran J Allergy Asthma Immunol 16:329–337PubMedGoogle Scholar
- Lucotte G, Bathelier C, Mercier G (2000) TNF-alpha polymorphisms in multiple sclerosis: no association with -238 and -308 promoter alleles, but the microsatellite allele a11 is associated with the disease in French patients. Mult Scler 6:78–80. https://doi.org/10.1177/135245850000600204 CrossRefPubMedGoogle Scholar
- Mahmoudian E, Khalilnezhad A, Gharagozli K, Amani D (2017) Thioredoxin-1, redox factor-1 and thioredoxin-interacting protein, mRNAs are differentially expressed in multiple sclerosis patients exposed and non-exposed to interferon and immunosuppressive treatments. Gene 634:29–36. https://doi.org/10.1016/j.gene.2017.08.021 CrossRefPubMedGoogle Scholar
- Matejcikova Z, Mares J, Sladkova V, Svrcinova T, Vyslouzilova J, Zapletalova J, Kanovsky P (2017) Cerebrospinal fluid and serum levels of interleukin-8 in patients with multiple sclerosis and its correlation with Q-albumin. Mult Scler Relat Disord 14:12–15. https://doi.org/10.1016/j.msard.2017.03.007 CrossRefPubMedGoogle Scholar
- Mohammadi N, Adib M, Alsahebfosoul F, Kazemi M, Etemadifar M (2016a) An investigation into the association between HLA-G 14 bp insertion/deletion polymorphism and multiple sclerosis susceptibility. J Neuroimmunol 290:115–118. https://doi.org/10.1016/j.jneuroim.2015.11.019 CrossRefPubMedGoogle Scholar
- Naghavian R, Ghaedi K, Kiani-Esfahani A, Ganjalikhani-Hakemi M, Etemadifar M, Nasr-Esfahani MH (2015) miR-141 and miR-200a, revelation of new possible players in modulation of Th17/Treg differentiation and pathogenesis of multiple sclerosis. PLoS ONE 10:e0124555. https://doi.org/10.1371/journal.pone.0124555 CrossRefPubMedPubMedCentralGoogle Scholar
- Rezaeepoor M, Shapoori S, Ganjalikhani-Hakemi M, Etemadifar M, Alsahebfosoul F, Eskandari N, Mansourian M (2017) Decreased expression of Sema3A, an immune modulator, in blood sample of multiple sclerosis patients. Gene 610:59–63. https://doi.org/10.1016/j.gene.2017.02.013 CrossRefPubMedGoogle Scholar
- Sanchooli J, Ramroodi N, Sanadgol N, Sarabandi V, Ravan H, Rad RS (2014) Relationship between metalloproteinase 2 and 9 concentrations and soluble CD154 expression in Iranian patients with multiple sclerosis. Kaohsiung J Med Sci 30:235–242. https://doi.org/10.1016/j.kjms.2013.12.008 CrossRefPubMedGoogle Scholar
- Schneider-Hohendorf T, Stenner MP, Weidenfeller C, Zozulya AL, Simon OJ, Schwab N, Wiendl H (2010) Regulatory T cells exhibit enhanced migratory characteristics, a feature impaired in patients with multiple sclerosis. Eur J Immunol 40:3581–3590. https://doi.org/10.1002/eji.201040558 CrossRefPubMedGoogle Scholar
- Soilu-Hanninen M, Laaksonen M, Laitinen I, Eralinna JP, Lilius EM, Mononen I (2008) A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis. J Neurol Neurosurg Psychiatry 79:152–157. https://doi.org/10.1136/jnnp.2006.105320 CrossRefPubMedGoogle Scholar
- Tao Y, Zhang X, Markovic-Plese S (2016) Toll-like receptor (TLR)7 and TLR9 agonists enhance interferon (IFN) beta-1a’s immunoregulatory effects on B cells in patients with relapsing-remitting multiple sclerosis (RRMS). J Neuroimmunol 298:181–188. https://doi.org/10.1016/j.jneuroim.2016.07.019 CrossRefPubMedGoogle Scholar
- Thurston RD et al. (2010) Tumor necrosis factor and interferon-gamma down-regulate Klotho in mice with colitis. Gastroenterology 138:1384-1394, e1381-1382 https://doi.org/10.1053/j.gastro.2009.12.002